SANUWAVE Health, Inc.

NASDAQ:SNWV

Medical - Devices

Healthcare
$5.93 +1.98%

+$0.18 today

Market cap
$51.01M
Beta
1.34
P/E (TTM)
5.0
EPS (TTM)
$1.87
52W Low $8.30High $46.59

Volume 0.04M

Average 0.11M

SNWV Depreciation & Amortization

Non-cash asset write-downs added back to net income because no cash left the business.

SANUWAVE Health, Inc.NASDAQ: SNWV

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization growth accelerates

Q1 FY2026 depreciation & amortization of $312K rose 13.9% year over year, ahead of the -90.0% change in trailing-twelve-month depreciation & amortization. Over 3 fiscal years it compounded at +10.5% a year.

Context

  • Depreciation & amortization amounted to 2.9% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Depreciation & amortization increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +13.9% holds above the trailing-twelve-month pace of -90.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$312K+137.3% QoQ
Last fiscal yearDec 2025
$1.28M+12.1% YoY
LTMMar 2026
$103K-90.0% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+13.9%——
1 year+12.1%——
3-year CAGR+10.5%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the cash flow

Latest · FY2025
1.28M USD
Year-over-year change
+12.1%
4-year CAGR
+0.9%

Depreciation & Amortization vs competitors

How SNWV compares with its peers on the latest reported figures

  • SNWV's LTM Mar 2026 depreciation & amortization of $103K is the smallest of the 11 companies compared; the peer median is $2.79M.
  • Its year-over-year change of -90.0% is the lowest of 11, against a peer median of +9.1%.
  • Depreciation & amortization amounts to 0.2% of revenue for SNWV, versus a peer median of 7.0%.
SNWV Competitors Peer median
Depreciation & Amortization for SNWV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
QTRXQuanterix CorporationLTM Mar 2026$22.58M +148.0%+52.4%15.6%
INGNInogen, Inc.LTM Mar 2026$20.37M -2.6%-4.2%5.8%
NNOXNano-X Imaging Ltd.LTM Dec 2025$11.7M -0.3%+0.5%89.8%
MASS908 Devices Inc.LTM Mar 2026$4.31M -7.1%+33.4%7.5%
FHTXFoghorn Therapeutics Inc.LTM Mar 2026$2.84M -8.0%-25.0%10.1%
OMOutset Medical, Inc.LTM Mar 2026$2.74M +63.9%-5.7%2.3%
SENSSenseonics Holdings, Inc.LTM Mar 2026$1.48M +102.1%-54.8%3.6%
SGHTSight Sciences, Inc.LTM Mar 2026$690K +3.1%-11.8%0.9%
HSDTSolana CompanyLTM Mar 2026$672K +1192.3%+30.5%7.0%
IMRXImmuneering CorporationLTM Mar 2026$531.13K +15.1%-4.3%—
SNWVSANUWAVE Health, Inc.LTM Mar 2026$103K -90.0%+10.5%0.2%
Peer median (excluding SNWV) $2.79M+9.1%-4.2%7.0%

Competitors are the stored peer set for SNWV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(27.26M)(10.29M)(25.81M)(31.37M)11.81M
Depreciation & Amortization1.24M952K1.03M1.15M1.28M
Deferred Income Tax28K2K4K00
Stock-Based Compensation0001.51M0
Change in Working Capital9.93M(1.12M)(3.61M)(2.9M)(4.01M)
Accounts Receivables(395K)(1.75M)(53K)(486K)(2.3M)
Inventory1.69M(72K)(2.8M)(1.2M)(2.28M)
Accounts Payables3.18M(2.55M)1.55M(1.42M)(521K)
Other Working Capital5.46M3.25M(2.3M)203K1.09M
Other Non-Cash Items9.66M(6.71M)23.84M34.07M(5.21M)
Operating Cash Flow(6.41M)(17.17M)(4.54M)2.46M3.88M
Capital Expenditures(529K)1.02M0(490K)(1.94M)
Acquisitions (Net)0332K000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities0(1.02M)21K05.38M
Investing Cash Flow(529K)332K21K(490K)3.43M
Debt Repayment3.38M16.59M5.85M(2.46M)(6.14M)
Common Stock Issued0100K010.3M556K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities1.74M695K(639K)(1.49M)0
Financing Cash Flow5.12M17.38M5.21M6.35M(5.59M)
Effect of Forex Changes(1K)(13K)(50K)121K0
Net Change in Cash(1.82M)534K644K8.44M1.72M
Free Cash Flow(6.94M)(16.15M)(4.54M)1.97M1.93M

SANUWAVE Health, Inc.

NASDAQ:SNWV

Intrinsic Alpha fair value

Locked

Current Price

$5.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.